Go to Contents
ABOUT US
Company History
Jennerex
Contact Us
TECHNOLOGY
SOLVE ®
GEEV ®
Scientific Publications
PIPELINE
Development Pipeline
Pexa-Vec
(JX-594)
BAL0891
SJ-600 Series
JX-900 Series
PARTNERSHIP
Pexa-Vec
Partnership
IR/PR
Publications & News
Financials
IR Inquiries
SillaJen Biotherapeutics
About SillaJen Biotherapeutics
Contact Us
Sillajen Sitemap
ABOUT US
Company History
Jennerex
Contact Us
TECHNOLOGY
SOLVE ®
GEEV ®
Scientific Publications
PIPELINE
Development Pipeline
Pexa-Vec (JX-594)
BAL0891
SJ-600 Series
JX-900 Series
PARTNERSHIP
Pexa-Vec Partnership
IR/PR
Publications & News
Financials
IR Inquiries
SillaJen Biotherapeutics
About SillaJen Biotherapeutics
Contact Us
ENG
|
KOR
ENG
ENG
KOR
Targeting, Attacking, and Eradicating Cancers®
TOP
IR/PR
ABOUT US
TECHNOLOGY
PIPELINE
PARTNERSHIP
IR/PR
SillaJen Biotherapeutics
Notice & News
Publications & News
Stock Information
Financials
IR Inquiries
Notice & News
게시판
SillaJen to use IPO proceeds to fund clinical trial of liver cancer drug in 11 countries
2016-11-14
Sillajen to use IPO proceeds to fund clinical trial of liver cancer drug in 11 countries
Link address :
http://pulsenews.co.kr/view.php?year=2016&no=791554
Targeting, Attacking, and Eradicating Cancers®
